Please provide your email address to receive an email when new articles are posted on . An FDA-cleared computer-assisted vacuum thrombectomy system was launched. The next-generation system is designed ...
Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.
Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Symphony(R) Thrombectomy System to treat pulmonary embolism (PE), a life-threatening condition ...
A subsegmental pulmonary embolism is a blood clot located on a distal, or distant and less central, branch of the pulmonary arteries. Treatment can depend on symptoms and risk factors. A subsegmental ...
Previously cleared by FDA to treat peripheral vasculature disease (PVD) and for autologous blood transfusion, the Aventus Thrombectomy System from Inquis Medical has a new 510(k) indication: pulmonary ...
The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...
A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.
Although D-dimer results within a typical range can rule out pulmonary embolism, high results alone can’t diagnose this condition. Doctors usually need to run extra tests to make a diagnosis. A ...
Chest pain after a pulmonary embolism is common and may last days or even weeks. In most cases, symptoms improve as the clot dissolves, but some people can develop chronic pain. This pain typically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback